chr10-122456893-T-TG
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001099667.3(ARMS2):c.298-14_298-13insG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00289 in 1,542,698 control chromosomes in the GnomAD database, including 60 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.012 ( 29 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 31 hom. )
Consequence
ARMS2
NM_001099667.3 intron
NM_001099667.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.213
Genes affected
ARMS2 (HGNC:32685): (age-related maculopathy susceptibility 2) This gene encodes a small secreted protein specific to primates. This protein is a component of the choroidal extracellular matrix of the eye. Mutations in this gene are associated with age-related macular degeneration. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 10-122456893-T-TG is Benign according to our data. Variant chr10-122456893-T-TG is described in ClinVar as [Likely_benign]. Clinvar id is 299030.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0118 (1802/152134) while in subpopulation AFR AF= 0.0397 (1645/41460). AF 95% confidence interval is 0.0381. There are 29 homozygotes in gnomad4. There are 849 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 29 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARMS2 | NM_001099667.3 | c.298-14_298-13insG | intron_variant | ENST00000528446.1 | NP_001093137.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMS2 | ENST00000528446.1 | c.298-14_298-13insG | intron_variant | 1 | NM_001099667.3 | ENSP00000436682.1 | ||||
ENSG00000285955 | ENST00000647969.1 | n.182+1601_182+1602insC | intron_variant | |||||||
ENSG00000285955 | ENST00000650300.1 | n.1852+1601_1852+1602insC | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0118 AC: 1796AN: 152016Hom.: 29 Cov.: 32
GnomAD3 genomes
AF:
AC:
1796
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 521AN: 150120Hom.: 10 AF XY: 0.00358 AC XY: 285AN XY: 79512
GnomAD3 exomes
AF:
AC:
521
AN:
150120
Hom.:
AF XY:
AC XY:
285
AN XY:
79512
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00191 AC: 2657AN: 1390564Hom.: 31 Cov.: 33 AF XY: 0.00201 AC XY: 1379AN XY: 685728
GnomAD4 exome
AF:
AC:
2657
AN:
1390564
Hom.:
Cov.:
33
AF XY:
AC XY:
1379
AN XY:
685728
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0118 AC: 1802AN: 152134Hom.: 29 Cov.: 32 AF XY: 0.0114 AC XY: 849AN XY: 74368
GnomAD4 genome
AF:
AC:
1802
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
849
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
26
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Macular degeneration Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at